Neuropathic pain associated with Nav1.7 mutations. Clinical picture and treatment

被引:3
|
作者
Doppler, K. [1 ]
Sommer, C. [1 ]
机构
[1] Univ Klinikum Wurzburg, Neurol Klin & Poliklin, D-97080 Wurzburg, Germany
来源
NERVENARZT | 2013年 / 84卷 / 12期
关键词
Nav1.7; SCN9A mutation; Small fiber neuropathy; Erythromelalgia; polymorphism; SMALL-FIBER NEUROPATHY; CHANNEL ALPHA-SUBUNIT; FAMILIAL ERYTHROMELALGIA; SODIUM-CHANNELS; NA(V)1.7; SCN9A; DISORDER; POLYMORPHISM; ERYTHERMALGIA; SYMPTOMS;
D O I
10.1007/s00115-012-3621-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Voltage-gated sodium channels are essential for electrogenesis in excitable cells. The isoform Nav1.7 is primarily expressed in nociceptors. Mutations of the SCN9A gene, which codes for the alpha-subunit of Nav1.7, are the cause of primary erythromelalgia and paroxysmal extreme pain disorder, two rare neuropathic pain conditions. Recent studies have shown that mutations in the SCN9A gene are the cause of a subgroup of idiopathic small fiber neuropathies and that polymorphisms of SCN9A are associated with an increase in susceptibility to pain. These findings not only contribute to the understanding of the pathophysiology of neuropathic pain but also offer targets for a more specific pain therapy.
引用
收藏
页码:1428 / +
页数:6
相关论文
共 50 条
  • [21] Navigating a new path to Nav1.7 for pain
    Katie Kingwell
    Nature Reviews Drug Discovery, 2022, 21 : 18 - 18
  • [22] NaV1.7 and pain: contribution of peripheral nerves
    Hoffmann, Tal
    Sharon, Ohad
    Wittmann, Juergen
    Carr, Richard W.
    Vyshnevska, Alina
    De Col, Roberto
    Nassar, Mohammed A.
    Reeh, Peter W.
    Weidner, Christian
    PAIN, 2018, 159 (03) : 496 - 506
  • [23] A NEW NAV1.7 SODIUM CHANNEL HAPLOTYPE ASSOCIATED WITH RESPONSIVENESS TO DULOXETINE: A PHARMACOGENOMICS STUDY OF NEUROPATHIC PAIN THERAPY
    Kapetis, D.
    Pierro, T.
    Galbardi, B.
    Lauria, G. P.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2014, 19 : S17 - S17
  • [24] No Gain, No Pain: Nav1.7 as an Analgesic Target
    King, Glenn F.
    Vetter, Irina
    ACS CHEMICAL NEUROSCIENCE, 2014, 5 (09): : 749 - 751
  • [25] Nav1.7 withholds its pain potential
    Kingwell, Katie
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (05) : 321 - 323
  • [26] Navigating a new path to Nav1.7 for pain
    Kingwell, Katie
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (01) : 18 - 18
  • [27] Two novel mutations of SCN9A (Nav1.7) are associated with partial congenital insensitivity to pain
    Staud, Roland
    Price, Donald D.
    Janicke, David
    Andrade, Edgard
    Hadjipanayis, Angela G.
    Eaton, Will T.
    Kaplan, Lee
    Wallace, Margaret R.
    EUROPEAN JOURNAL OF PAIN, 2011, 15 (03) : 223 - 230
  • [28] Nav1.7 Inhibitors: Potential Effective Therapy for the Treatment of Chronic Pain
    Abdel-Magid, Ahmed F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (09): : 956 - 957
  • [29] Drug screening reveals inhibitors of NaV1.7 sodium channels and a pain-relevant NaV1.7 variant
    Kesdogan, A.
    Raemisch, S.
    Kriegeskorte, S.
    Bott, R.
    Rolke, R.
    Koerner, J.
    Lampert, A.
    Hausmann, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S44 - S45
  • [30] Discovery of clinical candidate GDC-0276: A selective NaV1.7 inhibitor for the treatment of pain
    Sutherlin, Daniel
    Sun, Shaoyi
    Chowdhury, Sultan
    Jia, Qi
    Zenova, Alla
    Wilson, Michael
    Focken, Thilo
    Li, Jun
    Bichler, Paul
    Decker, Shannon
    Grimwood, Mike
    Hemeon, Ivan
    Sheng, Tao
    Andrez, Jean-Christophe
    Hackos, David
    Bankar, Girish
    Khakh, Kuldip
    Chang, Elaine
    Kwan, Rainbow
    Lin, Sohia
    Nelkenbrecher, Karen
    Ortwine, Daniel
    Chang, Jae
    Pang, Jodie
    Sojo, Luis
    Chiang, Po-chang
    Sambrone, Amy
    Tagen, Michael
    White, Andrew
    Chen, Chien-An
    Chen, John
    Lovelidge, Jane
    Ding, Xiao
    Takahashi, Ryan
    Waldbrook, Matthew
    Xie, Zhiwei
    Young, Clint
    Robinette, Lee
    Cohen, Charles
    Oballa, Renata
    Dehnhardt, Christoph
    Safina, Brian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254